BlackRock’s Strata Skin Sciences SSKN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,465
| Closed | -$5.63K | – | 5794 |
|
|
2025
Q4 | $5.63K | Hold |
4,465
| – | – | ﹤0.01% | 5338 |
|
|
2025
Q3 | $9.2K | Hold |
4,465
| – | – | ﹤0.01% | 5219 |
|
|
2025
Q2 | $10.2K | Sell |
4,465
-617
| -12% | -$1.54K | ﹤0.01% | 5220 |
|
|
2025
Q1 | $13.4K | Hold |
5,082
| – | – | ﹤0.01% | 5142 |
|
|
2024
Q4 | $14.8K | Hold |
5,082
| – | – | ﹤0.01% | 5138 |
|
|
2024
Q3 | $14K | Sell |
5,082
-957
| -16% | -$2.99K | ﹤0.01% | 4970 |
|
|
2024
Q2 | $18.5K | Sell |
6,039
-3,595
| -37% | -$14.6K | ﹤0.01% | 5014 |
|
|
2024
Q1 | $36.4K | Sell |
9,634
-110
| -1% | -$574 | ﹤0.01% | 4935 |
|
|
2023
Q4 | $53.6K | Sell |
9,744
-174
| -2% | -$904 | ﹤0.01% | 4955 |
|
|
2023
Q3 | $59K | Sell |
9,918
-191
| -2% | -$1.47K | ﹤0.01% | 4971 |
|
|
2023
Q2 | $96K | Sell |
10,109
-257
| -2% | -$2.53K | ﹤0.01% | 4928 |
|
|
2023
Q1 | $110K | Sell |
10,366
-767
| -7% | -$7.71K | ﹤0.01% | 4934 |
|
|
2022
Q4 | $88K | Buy |
11,133
+132
| +1% | +$1.13K | ﹤0.01% | 5084 |
|
|
2022
Q3 | $96K | Sell |
11,001
-165
| -1% | -$1.68K | ﹤0.01% | 5187 |
|
|
2022
Q2 | $107K | Sell |
11,166
-99
| -0.9% | -$1.18K | ﹤0.01% | 5222 |
|
|
2022
Q1 | $166K | Sell |
11,265
-297
| -3% | -$4.43K | ﹤0.01% | 5151 |
|
|
2021
Q4 | $169K | Buy |
11,562
+272
| +2% | +$4.51K | ﹤0.01% | 5141 |
|
|
2021
Q3 | $208K | Sell |
11,290
-132
| -1% | -$2.01K | ﹤0.01% | 4978 |
|
|
2021
Q2 | $178K | Sell |
11,422
-999
| -8% | -$15.5K | ﹤0.01% | 4919 |
|
|
2021
Q1 | $208K | Buy |
12,421
+669
| +6% | +$12.1K | ﹤0.01% | 4736 |
|
|
2020
Q4 | $176K | Buy |
11,752
+243
| +2% | +$3.5K | ﹤0.01% | 4492 |
|
|
2020
Q3 | $155K | Sell |
11,509
-122
| -1% | -$1.69K | ﹤0.01% | 4446 |
|
|
2020
Q2 | $133K | Buy |
11,631
+651
| +6% | +$7.72K | ﹤0.01% | 4443 |
|
|
2020
Q1 | $104K | Buy |
10,980
+1,134
| +12% | +$18.7K | ﹤0.01% | 4344 |
|
|
2019
Q4 | $205K | Buy |
9,846
+393
| +4% | +$8.92K | ﹤0.01% | 4312 |
|
|
2019
Q3 | $203K | Buy |
9,453
+1,156
| +14% | +$27.1K | ﹤0.01% | 4325 |
|
|
2019
Q2 | $207K | Buy |
8,297
+2,080
| +33% | +$51.9K | ﹤0.01% | 4362 |
|
|
2019
Q1 | $177K | Hold |
6,217
| – | – | ﹤0.01% | 4257 |
|
|
2018
Q4 | $162K | Hold |
6,217
| – | – | ﹤0.01% | 4272 |
|
|
2018
Q3 | $220K | Sell |
6,217
-11
| -0.2% | -$270 | ﹤0.01% | 4299 |
|
|
2018
Q2 | $127K | Hold |
6,228
| – | – | ﹤0.01% | 4420 |
|
|
2018
Q1 | $72K | Hold |
6,228
| – | – | ﹤0.01% | 4396 |
|
|
2017
Q4 | $76K | Hold |
6,228
| – | – | ﹤0.01% | 4377 |
|
|
2017
Q3 | $110K | Hold |
6,228
| – | – | ﹤0.01% | 4350 |
|
|
2017
Q2 | $151K | Sell |
6,228
-353
| -5% | -$9.83K | ﹤0.01% | 4321 |
|
|
2017
Q1 | $199K | Buy |
6,581
+6,570
| +59,727% | +$187K | ﹤0.01% | 4214 |
|
|
2016
Q4 | $0 | Hold |
11
| – | – | ﹤0.01% | 3806 |
|
|
2016
Q3 | $0 | Hold |
11
| – | – | ﹤0.01% | 3748 |
|
|
2016
Q2 | $0 | Hold |
11
| – | – | ﹤0.01% | 3808 |
|
|
2016
Q1 | $1K | Hold |
11
| – | – | ﹤0.01% | 3557 |
|
|
2015
Q4 | $1K | Buy |
+11
| New | +$629 | ﹤0.01% | 3394 |
|
BlackRock's SSKN Position: Q1 2026 in Review
BlackRock sold out of Strata Skin Sciences (SSKN) in Q1 2026, closing a stake of 4,465 shares — an estimated $5.63K sold.
BlackRock first reported a position in SSKN in Q4 2015 and held it in 41 quarters. The position peaked at $220K in Q3 2018. 0 funds tracked by Wall St. Rank hold SSKN as of Q1 2026.
- BlackRock reported no remaining Strata Skin Sciences position as of Q1 2026 after selling out during the quarter.
- BlackRock sold 4,465 Strata Skin Sciences shares in Q1 2026, an estimated $5.63K.
- BlackRock first reported a position in Strata Skin Sciences in Q4 2015 and held it in 41 quarters.
- BlackRock's Strata Skin Sciences position peaked at $220K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.